Rare diseases
Investigational molecules
Locations
Back to Poland1 824 clinical trials in Warsaw, Poland across 33 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of RO7837195 injection compared to placebo to treat moderate to severe ulcerative colitis
PolandStudy of patritumab deruxtecan versus drug combination in patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer
PolandStudy of NBI-1065845 as add-on treatment to prevent depression relapse in adults with Major Depressive Disorder who responded to initial treatment
PolandStudy of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months
PolandStudy of raludotatug deruxtecan, ifinatamab deruxtecan and docetaxel in patients with previously treated stage IV squamous non-small cell lung cancer
PolandStudy of ifinatamab deruxtecan, raludotatug deruxtecan and docetaxel in previously treated stage IV non-small cell lung cancer patients
PolandStudy of Atacicept Treatment for Patients with Multiple Autoimmune Glomerular Diseases
PolandStudy of Rilvegostomig with Bevacizumab and Tremelimumab as First-line Treatment for Patients with Advanced Liver Cancer
PolandStudy of BMS-986368 to treat muscle stiffness in people with Multiple Sclerosis
PolandStudy of MK-1084, cetuximab and mFOLFOX6 combination compared to mFOLFOX6 with or without bevacizumab for patients with KRAS G12C-mutant advanced colorectal cancer
PolandStudy of ABBV-453 alone or with drug combination for adults with multiple myeloma: evaluation of safety and effectiveness
PolandStudy of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) prevention in older adults. Studies include evaluation of novel vaccine formulations and immune responses in various age groups.
Particular emphasis on vaccine development for adults aged 60 and older.
Comprehensive research on meningococcal vaccines across different age groups, from infants to toddlers. Studies evaluate safety profiles and immune responses to various vaccine formulations.
Focus on preventive healthcare through advanced vaccination strategies.
Studies investigating treatments for psoriasis and psoriatic arthritis, including novel biological therapies and their mechanisms of action.
Emphasis on moderate to severe cases requiring advanced therapeutic interventions.
Clinical research focusing on bladder cancer and innovative combination therapies. Studies evaluate treatment efficacy in early-stage non-muscle invasive cases.
Integration of targeted therapies with standard treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
